NO952761D0 - Piperidinestere, fremgangsmåte for deres fremstilling og anvendelse som terapeutika - Google Patents
Piperidinestere, fremgangsmåte for deres fremstilling og anvendelse som terapeutikaInfo
- Publication number
- NO952761D0 NO952761D0 NO952761A NO952761A NO952761D0 NO 952761 D0 NO952761 D0 NO 952761D0 NO 952761 A NO952761 A NO 952761A NO 952761 A NO952761 A NO 952761A NO 952761 D0 NO952761 D0 NO 952761D0
- Authority
- NO
- Norway
- Prior art keywords
- therapeutics
- preparation
- methods
- piperidine esters
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9408711A FR2722497B1 (fr) | 1994-07-13 | 1994-07-13 | Esters de alpha-4-chlorophenyl)-4-(4-fluorophenyl)methyl) piperidine-1-ethanol, leur preparation et leur application en therapeutique |
Publications (3)
Publication Number | Publication Date |
---|---|
NO952761D0 true NO952761D0 (no) | 1995-07-12 |
NO952761L NO952761L (no) | 1996-01-15 |
NO304427B1 NO304427B1 (no) | 1998-12-14 |
Family
ID=9465359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO952761A NO304427B1 (no) | 1994-07-13 | 1995-07-12 | Piperidinester og medikament og farmas°ytisk preparat omfattende denne |
Country Status (19)
Country | Link |
---|---|
US (1) | US5620990A (no) |
EP (1) | EP0692472A1 (no) |
JP (1) | JPH0859616A (no) |
KR (1) | KR960004322A (no) |
CN (1) | CN1120038A (no) |
AU (1) | AU695312B2 (no) |
CA (1) | CA2153726A1 (no) |
CZ (1) | CZ180795A3 (no) |
FI (1) | FI953410A (no) |
FR (1) | FR2722497B1 (no) |
HU (1) | HU215599B (no) |
IL (1) | IL114562A (no) |
NO (1) | NO304427B1 (no) |
NZ (1) | NZ272552A (no) |
PL (1) | PL309589A1 (no) |
RU (1) | RU95113144A (no) |
SK (1) | SK88795A3 (no) |
TW (1) | TW374084B (no) |
ZA (1) | ZA955801B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6046213A (en) * | 1994-08-18 | 2000-04-04 | Pfizer Inc. | Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives |
ES2235368T3 (es) * | 1997-10-27 | 2005-07-01 | Sumitomo Pharmaceuticals Company, Limited | Derivados de amida para tratar alteraciones neurodegenerativas de la retina. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2534580A1 (fr) * | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
FR2628740B3 (fr) * | 1989-04-12 | 1990-01-19 | Synthelabo | Procede de preparation des enantiomeres du (chloro-4 phenyl)-1 (((fluoro-4 phenyl)methyl)-4 piperidyl-1)-2 ethanol |
ES2060547B1 (es) * | 1992-06-04 | 1995-06-16 | Ferrer Int | Mejoras en el objeto de la patente de invencion n/ 9201158 que se refiere a "procedimiento de obtencion de nuevos derivados de la 4-bencilpiperidina". |
FR2694555A1 (fr) * | 1992-08-05 | 1994-02-11 | Synthelabo | Procédé de péparation des énantiomères du 1-(4-chloro-2-hydroxyphényl)-2-[4-[(4-fluorophényl)méthyl]-piperidin-1-yl]éthanol. |
US5434171A (en) * | 1993-12-08 | 1995-07-18 | Eli Lilly And Company | Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates |
-
1994
- 1994-07-13 FR FR9408711A patent/FR2722497B1/fr not_active Expired - Fee Related
-
1995
- 1995-07-05 TW TW084106936A patent/TW374084B/zh active
- 1995-07-10 EP EP95401658A patent/EP0692472A1/fr not_active Withdrawn
- 1995-07-11 US US08/499,918 patent/US5620990A/en not_active Expired - Fee Related
- 1995-07-12 IL IL11456295A patent/IL114562A/xx active IP Right Grant
- 1995-07-12 NO NO952761A patent/NO304427B1/no not_active IP Right Cessation
- 1995-07-12 KR KR1019950020426A patent/KR960004322A/ko not_active Application Discontinuation
- 1995-07-12 FI FI953410A patent/FI953410A/fi unknown
- 1995-07-12 CZ CZ951807A patent/CZ180795A3/cs unknown
- 1995-07-12 JP JP7176013A patent/JPH0859616A/ja active Pending
- 1995-07-12 RU RU95113144/04A patent/RU95113144A/ru unknown
- 1995-07-12 AU AU24922/95A patent/AU695312B2/en not_active Ceased
- 1995-07-12 CN CN95108920A patent/CN1120038A/zh active Pending
- 1995-07-12 PL PL95309589A patent/PL309589A1/xx unknown
- 1995-07-12 ZA ZA955801A patent/ZA955801B/xx unknown
- 1995-07-12 CA CA002153726A patent/CA2153726A1/en not_active Abandoned
- 1995-07-12 HU HU9502113A patent/HU215599B/hu not_active IP Right Cessation
- 1995-07-12 SK SK887-95A patent/SK88795A3/sk unknown
- 1995-07-12 NZ NZ272552A patent/NZ272552A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL114562A (en) | 1999-11-30 |
US5620990A (en) | 1997-04-15 |
RU95113144A (ru) | 1997-06-27 |
EP0692472A1 (fr) | 1996-01-17 |
FR2722497A1 (fr) | 1996-01-19 |
TW374084B (en) | 1999-11-11 |
AU2492295A (en) | 1996-01-25 |
SK88795A3 (en) | 1996-02-07 |
HUT73137A (en) | 1996-06-28 |
NZ272552A (en) | 1996-06-25 |
HU9502113D0 (en) | 1995-09-28 |
JPH0859616A (ja) | 1996-03-05 |
HU215599B (hu) | 1999-01-28 |
NO952761L (no) | 1996-01-15 |
CZ180795A3 (en) | 1996-01-17 |
CA2153726A1 (en) | 1996-01-14 |
KR960004322A (ko) | 1996-02-23 |
CN1120038A (zh) | 1996-04-10 |
FR2722497B1 (fr) | 1996-08-14 |
NO304427B1 (no) | 1998-12-14 |
IL114562A0 (en) | 1995-11-27 |
FI953410A0 (fi) | 1995-07-12 |
AU695312B2 (en) | 1998-08-13 |
ZA955801B (en) | 1996-04-25 |
PL309589A1 (en) | 1996-01-22 |
FI953410A (fi) | 1996-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO944187D0 (no) | Isokinoliner, fremgangsmåte for deres fremstilling og anvendelse | |
NO985977D0 (no) | Spiro-piperidinderivater og deres anvendelse som terapeutiske midler | |
NO990551D0 (no) | Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister | |
NO991815D0 (no) | Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter | |
DK1538160T3 (da) | Substituerede isochinolin-3-carboxylsyreamider, deres fremstilling og deres anvendelse som lægemiddel | |
NO990012D0 (no) | Nye erytromyciner og fremgangsmÕte for deres fremstilling | |
NO991761D0 (no) | Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse | |
DK0906292T3 (da) | Triazolylmercaptider og deres anvendelse som mikrobicider | |
NO980720D0 (no) | Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling | |
NO20003067L (no) | Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling | |
DK0832104T3 (da) | Dolastatinderivater, deres fremstilling og anvendelse | |
NO943682D0 (no) | Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse | |
NO981522D0 (no) | Aminosyrederivater, deres fremstilling og anvendelse som endotelinantagonister | |
NO994510D0 (no) | Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter | |
NO955326D0 (no) | Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse | |
DK0764157T3 (da) | Benzopyraner og deres anvendelse som terapeutiske midler | |
NO985307L (no) | Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvende | |
NO995513L (no) | N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK- | |
NO975020D0 (no) | Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi | |
NO951418D0 (no) | Peptidderivater, deres fremstilling og anvendelse som terapeutika | |
NO951147D0 (no) | Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel | |
NO941517L (no) | 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse | |
NO922842L (no) | Benzotiazolderivater, fremgangsmaate for deres fremstilling og deres anvendelse som terapeutika | |
NO954763D0 (no) | Piperidinderivater, deres fremstilling og anvendelse | |
NO20021007L (no) | Substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-oner og deres anvendelse som lipasehemmere |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JANUARY 2001 |